Plasma levels of estradiol do not necessarily reflect tissue-level activity as peripherally formed estradiol is partially metabolized in situ; thus, not all enters the general circulation, with a fraction remaining only locally active. Of the factors influencing plasma estradiol levels, plasma ...
Men with breast cancer who were treated with Soltamox plus gonadotropin-releasing hormone analogue had a decrease in estradiol levels of 85%, whereas Aromasin plus gonadotropin-releasing hormone analogue reduced these levels by 72%. Treating men with breast cancer with either an aromatase inhibitor ...
Elderly men have estradiol levels of 25–60 pmol/L. However, as previously noted, estradiol levels in men treated with GnRH agonists are reduced by approximately 80% [163, 164]. Oral estrogens had been used for more than 30 years to treat prostate cancer, but the benefits were overshadowed...
May be used in appropriate patients for the palliative care of breast cancer in women or men with metastatic disease. May be used in the palliation of advanced androgen-dependent prostate cancer. May be considered for the prevention of postmenopausal osteoporosis in women at significant risk and ...
Sometimes it is used in the in vitro programs Some doctors may occasionally prescribe estradiol medications as part of a comprehensive breast cancer treatment plan for women and, less frequently, to treat advanced forms of prostate cancer in men. ...
Despite a fair amount of data on the role of hormones and erection and ejaculation, it is inconclusive due to controversy in the current literature. To explore the correlation of male sexual dysfunction with hormonal profile, 1,076 men between the ages of 19–60 years (mean: 32.12 years) ...
The gonadotropin response of men with varicoceles to a four-hour infusion of gonadotropin-releasing hormone The serum gonadotropin, testosterone, and estradiol responses to a 4-hour intravenous infusion of gonadotropin-releasing hormone (GnRH) were studied in fou... RW Hudson,VA Crawford,DE Mckay...
Large doses of estrogen (5 mg conjugated estrogens per day), comparable to those used to treat cancer of the prostate and breast, have been shown in a large prospective clinical trial in men to increase the risks of nonfatal myocardial infarction, pulmonary embolism, and thrombophlebitis. b...
In women, it is used in hormone therapy for menopausal symptoms and low estrogen levels, hormone therapy for transgender women, and in hormonal birth control. It is also used in the treatment of prostate cancer in men. The medication is taken by mouth or by injection into muscle or fat ...
A. Transdermal testosterone replacement therapy in men. Drug Des. Devel. Ther. 8, 101–112 (2014). CAS PubMed PubMed Central Google Scholar Kapoor, D., Goodwin, E., Channer, K. S. & Jones, T. H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral ...